저자(한글) |
Biller, T.,Fatterpekar, G.,Nirenberg, M.,Brys, M. |
저자(영문) |
|
소속기관 |
|
소속기관(영문) |
|
출판인 |
|
간행물 번호 |
|
발행연도 |
2016-01-01 |
초록 |
A new gadolinium diethylenetriamine pentaacetic acid (DTPA) complex (Gd-DTPA-DMABA-CS 11 ) as a potential bimodal magnetic resonance imaging (MRI) contrast agent with fluorescence was synthesized. It was synthesized by the incorporation of 4-dimethylaminobenzaldehyde (DMABA) and chitosan oligosaccharide (CS n ; n=11) with low polydispersity index to DTPA anhydride and then chelated with gadolinium chloride. The structure was characterized by Fourier transform infrared (FTIR), 1 H NMR, elemental analysis and size exclusion chromatography (SEC). MRI measurements in vitro were evaluated. The results indicated that Gd-DTPA-DMABA-CS 11 provided higher molar longitudinal relaxivity (r 1 ) (12.95mM -1 .s -1 ) than that of commercial Gd-DTPA (3.63mM -1 .s -1 ) at 0.5T. Gd-DTPA-DMABA-CS 11 also emitted fluorescence, and the intensity was much stronger than that of Gd-DTPA. Therefore, it can be meanwhile used in fluorescent imaging for improving the sensitivity in clinic diagnosis. Gd-DTPA-DMABA-CS 11 as a potential contrast agent is preliminarily stable in vitro. The results of thermodynamic action between Gd-DTPA-DMABA-CS 11 and bovine serum albumin (BSA) illustrated that the binding process was exothermic and spontaneous, and the main force was van der Waals' interaction and hydrogen bond. The preliminary study suggested that Gd-DTPA-DMABA-CS 11 could be used in both magnetic resonance and fluorescent imaging as a promising bimodal contrast agent. |
원문URL |
http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=03553784&target=NART&cn=NART74645320 |
첨부파일 |
|